Alonso Haysom-Rodriguez

Dr. Alonso Haysom-Rodriguez is a Research Scientist in Medicinal Chemistry at Bicycle Therapeutics, where he specializes in developing and optimizing novel Bicycle® Radionuclide Conjugates (BRCs). He contributes to advancing molecules from earlystage design into lead optimisation. Alonso joined Bicycle after earning his PhD in Medicinal Chemistry from the University of Kansas, where his research focused on photoredox-catalysed peptide modifications and the evaluation of bioactive peptides.